MAPT and Alzheimer disease: Although the introduction of wild-type forms of APP and PSEN1, as found in normal and non-familial AD cases, does not elicit AD pathology in mice, the transgenic mice overexpressing pathological human mutant proteins easily show Aβ aggregation, cognitive deficits, and some abnormal tau phosphorylation [5,6,7].